flumazenil has been researched along with Cancer of Ovary in 2 studies
Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Provencio, M | 1 |
Espinosa, R | 1 |
Sánchez, A | 1 |
España, P | 1 |
Díez, O | 1 |
Doménech, M | 1 |
Alonso, MC | 1 |
Brunet, J | 1 |
Sanz, J | 1 |
Cortés, J | 1 |
del Río, E | 1 |
Baiget, M | 1 |
2 other studies available for flumazenil and Cancer of Ovary
Article | Year |
---|---|
Flumazenil in the treatment of dizziness and vegetative symptoms after intravenous infusion of paclitaxel.
Topics: Antidotes; Antineoplastic Agents, Phytogenic; Dizziness; Female; Flumazenil; Humans; Infusions, Intr | 2008 |
Identification of the 185delAG BRCA1 mutation in a Spanish Gypsy population.
Topics: Adult; Breast Neoplasms; Female; Genes, BRCA1; Genetic Markers; Humans; Jews; Mutation; Ovarian Neop | 1998 |